Atlas Trials

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Clinical trial NCT00667121 · COMPLETED

Trial details

NCT number
NCT00667121
Sponsor
Mayo Clinic
Status
COMPLETED
Study type
OBSERVATIONAL
Breast CancerDepressionHot FlashesPsychosocial Effects of Cancer and Its Treatment
Start date
2011-03-16
Primary completion
2014-05-12
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.